News

A Weight Loss Drug Candidate Essentially For Free As Skye Bioscience Is Trading At Cash Value
Skye Bioscience currently trades essentially at cash value, meaning investors who buy in today get a weight loss drug ...
Rising drug prices are hammering patients, employers, and insurers. Is there any end in sight?
Like tens of thousands of Massachusetts residents, community college professor Carolyn McGrath has been paying for medicine ...
Why Eli Lilly Stock Is Soaring Today, While Novo Nordisk and Viking Therapeutics Slide
Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( ...
Viking Therapeutics: Trading The Volatility Of The Weight Loss Drug Market
Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...
Healthline10d
Weight Loss Medications: A Dietitian Explains Everything You Need to Know
When paired with other lifestyle changes and taken under the supervision of a healthcare professional, these drugs ... long-term weight loss maintenance as well. Current list price: According ...
Boston Herald10d
The skyrocketing cost of weight-loss drugs has state Medicaid programs looking for a solution
One solution some policymakers may try is restricting the number of people on Medicaid who can use the pricey diabetes drugs for weight-loss purposes ... Hospital prices remain largely ...
Patients Cut Off From Cheaper Obesity Drugs as the F.D.A. Halts Sales of Copycats
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...